Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Walnut Creek. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Walnut Creek at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
This will be a clinical study to assess initial safety and tolerability of IVT ABI-110 in patients diagnosed with wet macular degeneration (wAMD), including symptomatic macular PCV.
Sponsor: Avirmax Biopharma Inc
Check if you qualify for this macular degeneration clinical trial in Walnut Creek, CA
If you're searching for macular degeneration treatment options in Walnut Creek, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Walnut Creek research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.